1. Home
  2. MRSN vs SYPR Comparison

MRSN vs SYPR Comparison

Compare MRSN & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • SYPR
  • Stock Information
  • Founded
  • MRSN 2001
  • SYPR 1997
  • Country
  • MRSN United States
  • SYPR United States
  • Employees
  • MRSN N/A
  • SYPR N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • SYPR Industrial Machinery/Components
  • Sector
  • MRSN Health Care
  • SYPR Industrials
  • Exchange
  • MRSN Nasdaq
  • SYPR Nasdaq
  • Market Cap
  • MRSN 40.7M
  • SYPR 36.8M
  • IPO Year
  • MRSN 2017
  • SYPR 1994
  • Fundamental
  • Price
  • MRSN $0.37
  • SYPR $1.94
  • Analyst Decision
  • MRSN Strong Buy
  • SYPR
  • Analyst Count
  • MRSN 5
  • SYPR 0
  • Target Price
  • MRSN $5.75
  • SYPR N/A
  • AVG Volume (30 Days)
  • MRSN 3.1M
  • SYPR 30.4K
  • Earning Date
  • MRSN 05-15-2025
  • SYPR 05-14-2025
  • Dividend Yield
  • MRSN N/A
  • SYPR N/A
  • EPS Growth
  • MRSN N/A
  • SYPR N/A
  • EPS
  • MRSN N/A
  • SYPR N/A
  • Revenue
  • MRSN $34,006,000.00
  • SYPR $134,135,000.00
  • Revenue This Year
  • MRSN N/A
  • SYPR N/A
  • Revenue Next Year
  • MRSN N/A
  • SYPR N/A
  • P/E Ratio
  • MRSN N/A
  • SYPR N/A
  • Revenue Growth
  • MRSN N/A
  • SYPR N/A
  • 52 Week Low
  • MRSN $0.26
  • SYPR $1.30
  • 52 Week High
  • MRSN $2.83
  • SYPR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 51.71
  • SYPR 61.83
  • Support Level
  • MRSN $0.33
  • SYPR $1.75
  • Resistance Level
  • MRSN $0.38
  • SYPR $2.07
  • Average True Range (ATR)
  • MRSN 0.04
  • SYPR 0.13
  • MACD
  • MRSN 0.00
  • SYPR 0.04
  • Stochastic Oscillator
  • MRSN 58.60
  • SYPR 75.93

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

Share on Social Networks: